论文信息 - U.S. Food and Drug Administration Approval Summary: Brentuximab Vedotin for the Treatment of Relapsed Hodgkin Lymphoma or Relapsed Systemic Anaplastic Large-Cell Lymphoma - 字舞流文

U.S. Food and Drug Administration Approval Summary: Brentuximab Vedotin for the Treatment of Relapsed Hodgkin Lymphoma or Relapsed Systemic Anaplastic Large-Cell Lymphoma

R. Pazdur | A. Khandelwal | F. Borrego | M. Rothmann | A. Farrell | V. Kwitkowski | H. Saber | B. Habtemariam | J. Bullock | J. Brown | R. Kane | E. Kaminskas | K. Clouse | M. Shapiro | R. A. de Claro | Yanli Ouyang | X. H. Chen | Karen M McGinn | Kallappa M. Koti | Kyung Lee | Lara Akinsanya | Mark Rothmann